vs
Side-by-side financial comparison of Apyx Medical Corp (APYX) and SIFCO INDUSTRIES INC (SIF). Click either name above to swap in a different company.
SIFCO INDUSTRIES INC is the larger business by last-quarter revenue ($24.0M vs $19.2M, roughly 1.3× Apyx Medical Corp). SIFCO INDUSTRIES INC runs the higher net margin — 7.5% vs -6.8%, a 14.2% gap on every dollar of revenue. On growth, Apyx Medical Corp posted the faster year-over-year revenue change (34.7% vs 14.8%). SIFCO INDUSTRIES INC produced more free cash flow last quarter ($8.0M vs $-2.8M). Over the past eight quarters, Apyx Medical Corp's revenue compounded faster (36.8% CAGR vs 8.1%).
Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.
SIFCO Industries, Inc. (SIFCO), is a global metal component manufacturer based in Cleveland, Ohio.
APYX vs SIF — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $19.2M | $24.0M |
| Net Profit | $-1.3M | $1.8M |
| Gross Margin | 62.6% | 21.6% |
| Operating Margin | 0.1% | 10.7% |
| Net Margin | -6.8% | 7.5% |
| Revenue YoY | 34.7% | 14.8% |
| Net Profit YoY | 71.9% | 177.3% |
| EPS (diluted) | — | $0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.2M | $24.0M | ||
| Q3 25 | $12.9M | $22.8M | ||
| Q2 25 | $11.4M | $22.1M | ||
| Q1 25 | $9.4M | $19.0M | ||
| Q4 24 | $14.2M | $20.9M | ||
| Q3 24 | $11.5M | $21.7M | ||
| Q2 24 | $12.1M | $22.0M | ||
| Q1 24 | $10.2M | $20.5M |
| Q4 25 | $-1.3M | $1.8M | ||
| Q3 25 | $-2.0M | $-429.0K | ||
| Q2 25 | $-3.8M | $3.4M | ||
| Q1 25 | $-4.2M | $-1.4M | ||
| Q4 24 | $-4.6M | $-2.3M | ||
| Q3 24 | $-4.7M | $-443.0K | ||
| Q2 24 | $-6.6M | $72.0K | ||
| Q1 24 | $-7.6M | $-1.6M |
| Q4 25 | 62.6% | 21.6% | ||
| Q3 25 | 64.4% | 9.6% | ||
| Q2 25 | 62.3% | 26.7% | ||
| Q1 25 | 60.1% | 8.3% | ||
| Q4 24 | 63.0% | 4.4% | ||
| Q3 24 | 60.5% | 10.7% | ||
| Q2 24 | 61.7% | 12.3% | ||
| Q1 24 | 58.1% | 7.3% |
| Q4 25 | 0.1% | 10.7% | ||
| Q3 25 | -6.5% | -1.7% | ||
| Q2 25 | -22.6% | 14.8% | ||
| Q1 25 | -32.4% | -4.1% | ||
| Q4 24 | -21.4% | -9.2% | ||
| Q3 24 | -31.6% | -1.5% | ||
| Q2 24 | -45.7% | 0.7% | ||
| Q1 24 | -64.6% | -6.5% |
| Q4 25 | -6.8% | 7.5% | ||
| Q3 25 | -15.4% | -1.9% | ||
| Q2 25 | -33.2% | 15.4% | ||
| Q1 25 | -44.0% | -7.3% | ||
| Q4 24 | -32.5% | -11.1% | ||
| Q3 24 | -40.9% | -2.0% | ||
| Q2 24 | -54.0% | 0.3% | ||
| Q1 24 | -74.0% | -7.8% |
| Q4 25 | — | $0.29 | ||
| Q3 25 | — | $-0.07 | ||
| Q2 25 | — | $0.56 | ||
| Q1 25 | — | $-0.23 | ||
| Q4 24 | — | $-0.38 | ||
| Q3 24 | — | $-0.07 | ||
| Q2 24 | $-0.19 | $0.01 | ||
| Q1 24 | $-0.22 | $-0.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.7M | $1.1M |
| Total DebtLower is stronger | $37.5M | $39.0K |
| Stockholders' EquityBook value | $14.5M | $38.7M |
| Total Assets | $66.8M | $74.9M |
| Debt / EquityLower = less leverage | 2.58× | 0.00× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.7M | $1.1M | ||
| Q3 25 | $25.1M | $491.0K | ||
| Q2 25 | $29.3M | $2.0M | ||
| Q1 25 | $31.0M | $1.9M | ||
| Q4 24 | $31.7M | $3.1M | ||
| Q3 24 | $28.0M | $1.7M | ||
| Q2 24 | $32.7M | $3.4M | ||
| Q1 24 | $37.3M | $2.5M |
| Q4 25 | $37.5M | $39.0K | ||
| Q3 25 | $37.5M | $51.0K | ||
| Q2 25 | $37.5M | — | ||
| Q1 25 | $37.5M | — | ||
| Q4 24 | $37.5M | — | ||
| Q3 24 | $37.5M | $0 | ||
| Q2 24 | — | $3.6M | ||
| Q1 24 | — | $4.1M |
| Q4 25 | $14.5M | $38.7M | ||
| Q3 25 | $5.8M | $36.9M | ||
| Q2 25 | $7.3M | $35.8M | ||
| Q1 25 | $10.5M | $32.4M | ||
| Q4 24 | $14.2M | $33.7M | ||
| Q3 24 | $11.0M | $30.4M | ||
| Q2 24 | $14.7M | $29.8M | ||
| Q1 24 | $20.3M | $29.7M |
| Q4 25 | $66.8M | $74.9M | ||
| Q3 25 | $57.4M | $73.4M | ||
| Q2 25 | $58.2M | $77.3M | ||
| Q1 25 | $60.2M | $78.8M | ||
| Q4 24 | $64.8M | $81.0M | ||
| Q3 24 | $60.7M | $104.6M | ||
| Q2 24 | $65.4M | $106.3M | ||
| Q1 24 | $70.7M | $104.2M |
| Q4 25 | 2.58× | 0.00× | ||
| Q3 25 | 6.41× | 0.00× | ||
| Q2 25 | 5.17× | — | ||
| Q1 25 | 3.57× | — | ||
| Q4 24 | 2.64× | — | ||
| Q3 24 | 3.40× | 0.00× | ||
| Q2 24 | — | 0.12× | ||
| Q1 24 | — | 0.14× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.5M | $8.1M |
| Free Cash FlowOCF − Capex | $-2.8M | $8.0M |
| FCF MarginFCF / Revenue | -14.6% | 33.3% |
| Capex IntensityCapex / Revenue | 1.4% | 0.4% |
| Cash ConversionOCF / Net Profit | — | 4.51× |
| TTM Free Cash FlowTrailing 4 quarters | $-9.1M | $11.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.5M | $8.1M | ||
| Q3 25 | $-3.5M | $726.0K | ||
| Q2 25 | $-1.2M | $371.0K | ||
| Q1 25 | $-702.0K | $2.8M | ||
| Q4 24 | $-2.9M | $-3.8M | ||
| Q3 24 | $-4.4M | $857.0K | ||
| Q2 24 | $-4.3M | $382.0K | ||
| Q1 24 | $-6.3M | $-3.2M |
| Q4 25 | $-2.8M | $8.0M | ||
| Q3 25 | $-4.1M | $566.0K | ||
| Q2 25 | $-1.5M | $310.0K | ||
| Q1 25 | $-757.0K | $2.7M | ||
| Q4 24 | $-3.2M | $-3.9M | ||
| Q3 24 | $-4.6M | $580.0K | ||
| Q2 24 | $-4.6M | $-175.0K | ||
| Q1 24 | $-6.4M | $-3.9M |
| Q4 25 | -14.6% | 33.3% | ||
| Q3 25 | -31.5% | 2.5% | ||
| Q2 25 | -13.2% | 1.4% | ||
| Q1 25 | -8.0% | 14.1% | ||
| Q4 24 | -22.4% | -18.8% | ||
| Q3 24 | -40.0% | 2.7% | ||
| Q2 24 | -38.0% | -0.8% | ||
| Q1 24 | -62.2% | -18.9% |
| Q4 25 | 1.4% | 0.4% | ||
| Q3 25 | 4.0% | 0.7% | ||
| Q2 25 | 2.3% | 0.3% | ||
| Q1 25 | 0.6% | 0.8% | ||
| Q4 24 | 1.7% | 0.5% | ||
| Q3 24 | 1.3% | 1.3% | ||
| Q2 24 | 2.4% | 2.5% | ||
| Q1 24 | 0.3% | 3.3% |
| Q4 25 | — | 4.51× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 5.31× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
APYX
Segment breakdown not available.
SIF
| Fixed Wing Aircraft Revenue | $10.5M | 44% |
| Commercial Revenue | $8.7M | 36% |
| Commercial Product And Other Revenue | $2.8M | 12% |
| Commercial Space | $1.1M | 5% |
| Other | $840.0K | 4% |
